Comments
Elon Musk’s SpaceX, an advanced rockets and spacecraft manufacturer company, carried out an anti-test program to track the prevalence of coronavirus among 4000 SpaceX workers across the United States.
The findings of the program revealed that a certain amount of antibodies against the virus may provide lasting immunity.
The study, published in the journal Nature Communications, is co-authored by Musk himself. “People can have antibodies, but it doesn’t mean they are going to be immune to Covid-19,” said Galit Alter, a co-author of the study and a member of the Ragon Institute of MGH, MIT and Harvard.
Also read: SpaceX Starship prototype rocket blows up on landing after test launch
The study noted that individuals who experienced fewer, milder Covid-19 symptoms generated fewer antibodies. Hence, mild symptoms were less likely to meet the antibodies threshold for longer-term immunity.
“To really nail this down at a public-health level would require doing reinfection studies and following people for reinfection over time,” said Joshua T. Schiffer, associate professor at the Fred Hutchinson Cancer Research Center’s vaccine and infectious-disease division.
Dr. Alter also added that scientists who carried out the study on SpaceX workers support the prioritization of vulnerable people for Covid-19 vaccination.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.